Plain-English translation of NCT07599592 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
United States
Sponsor
University of California, Los Angeles
Enrollment target
~20 participants
Started
May 2026
Primary completion
December 2026
Age range
18 Years – 90 Years
Last updated on clinicaltrials.gov in May 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Andrew Bishay
University of California, Los Angeles
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.